International Business News - MEDX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Medarex Inc. and the Massachusetts Biologics Laboratories said Monday that their two drug candidates reduced diarrhea in a clinical trial compared with a placebo. http://www.ibtimes.com/articles/20081103/medarex-says-drug-combo-reduced-diarrhea-in-trial.htm Mon, 03 Nov 2008 13:54:56 EST Among the premarket activity stories for Thursday, Sept. 11, from AP Financial News: WASHINGTON (AP)--Government data is expected to show that the number of newly laid-off people filing jobless benefit claims dipped slightly last week but remains at elevated levels due to the sluggish economy. http://www.ibtimes.com/articles/20080911/premarket-roundup-jobless-claims-foreign-trade.htm Thu, 11 Sep 2008 09:25:56 EDT A JPMorgan analyst downgraded shares of Medarex Inc. Thursday, saying the stock will trade in place until the second half of 2009, when Medarex reports critical late-stage trial data for its melanoma drug candidate ipilimumab. http://www.ibtimes.com/articles/20080911/ahead-of-the-bell-medarex-downgraded.htm Thu, 11 Sep 2008 07:44:19 EDT Medarex Inc. said Monday it received a milestone payment after Pfizer Inc. planned to begin clinical trials of a product Pfizer developed using Madera's ultimo technology. http://www.ibtimes.com/articles/20080908/medarex-gets-milestone-payment-from-pfizer.htm Mon, 08 Sep 2008 12:21:23 EDT Biotechnology company Medarex Inc. said late Tuesday its second-quarter loss widened on a mix of lower revenue and a charge related to its affiliate Avant Immunotherapeutics. http://www.ibtimes.com/articles/20080806/medarex-posts-wider-2q-loss-on-lower-revenue.htm Wed, 06 Aug 2008 13:57:51 EDT Among the stock activity stories for Monday, June 2, from AP Financial News: NEW YORK (AP)--Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concerns over the company's late-stage melanoma drug candidate ipilimumab. http://www.ibtimes.com/articles/20080602/movers-roundup-medarex-harris.htm Mon, 02 Jun 2008 14:18:30 EDT Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concerns over the company's late-stage melanoma drug candidate ipilimumab. http://www.ibtimes.com/articles/20080602/medarex-shares-fall-on-concerns-over-melanoma-data.htm Mon, 02 Jun 2008 19:31:24 EDT Among the stock activity stories for Wednesday, May 28, from AP Financial News: NEW YORK (AP)--Shares of Archer Daniels Midland Co. fell Wednesday, a day after the company said it will sell 35 million equity units for a total of up to $2 billion. http://www.ibtimes.com/articles/20080528/movers-roundup-archer-daniels-midland-medarex.htm Wed, 28 May 2008 14:34:23 EDT Shares of Medarex Inc. continued their recovery Wednesday after an analyst said the company will not receive any more bad news for its melanoma drug candidates for the rest of the year. http://www.ibtimes.com/articles/20080528/medarex-ticks-higher-as-analyst-predicts-recovery.htm Wed, 28 May 2008 17:47:45 EDT Shares of biotechnology company Medarex Inc. rose Tuesday after a Needham & Co. analyst raised his rating on shares to "Buy" from "Hold," based on the company's pipeline and developments expected throughout the year. http://www.ibtimes.com/articles/20080513/medarex-shares-rise-following-analyst-upgrade.htm Tue, 13 May 2008 12:01:22 EDT Among the earnings stories for Monday, May 12, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080512/earnings-roundup-sprint-nextel-gerdau-ameristeel.htm Mon, 12 May 2008 11:05:01 EDT Biotechnology company Medarex Inc. said Monday its first-quarter profit fell 6 percent, but adjusted results beat Wall Street's expectations. For the three months ended March 31, the company reported income of $103.3 million, or 76 cents per share, compared with $110.3 million, or 80 cents per share, in the year-ago period. http://www.ibtimes.com/articles/20080512/medarex-first-quarter-profit-slips-6-percent.htm Mon, 12 May 2008 08:22:26 EDT Biotechnology company Medarex Inc. said late Friday the Food and Drug Administration's request for more data on its cancer drug candidate will delay the application process into next year. http://www.ibtimes.com/articles/20080425/medarex-will-delay-cancer-drug-application-over-fda-request.htm Fri, 25 Apr 2008 17:06:39 EDT